EIN News (press release) Takeda conducted the global EXAMINE trial in accordance with the United States (U.S.) Food and Drug Administration's (FDA) 2008 Guidance, titled "Guidance for Industry: Diabetes Mellitus – Evaluating Cardiovascular Risk in New Antidiabetic Therapies to ... and more »
Endocrinology Update The company has requested an Authority Required (streamlined) listing for the combination in the treatment of type 2 diabetes in a patient whose HbA1c is greater than 7% prior to initiation of a DPP-4 inhibitor, a thiazolidinedione or a glucagon-like ...
Laboratory Equipment Hope comes in the form of a controversial drug , rosiglitazone, in the thiazolidinedione class of medications used in diabetes treatment, he says. The drug is suspected of causing heart problems over long-term use by diabetes patients. But tests on ...
UPI.com Hope comes in the form of a controversial drug , rosiglitazone, in the thiazolidinedione class of medications used in diabetes treatment, he said. The drug is suspected of causing heart problems over long-term use by diabetes patients, but tests on ... and more »
UPI.com Hope comes in the form of a controversial drug , rosiglitazone, in the thiazolidinedione class of medications used in diabetes treatment, he said. The drug is suspected of causing heart problems over long-term use by diabetes patients, but tests on ... and more »
Family Practice News Digital Network Available data on a possible link between antihyperglycemic drugs and an increased risk of pancreatitis and certain cancers do not justify making changes in clinical practice, according to a consensus statement on diabetes and cancer released by the ... and more »
Family Practice News Digital Network Available data on a possible link between antihyperglycemic drugs and an increased risk of pancreatitis and certain cancers do not justify making changes in clinical practice, according to a consensus statement on diabetes and cancer released by the ... and more »
Legal Examiner A study last year in the Journal of the National Cancer Institute found that patients taking TZD ( thiazolidinedione drugs , including Actos and Avandia) for more than five years had two to three times the incidence of bladder cancer as patients taking ... and more »
Family Practice News Digital Network Available data on a possible link between antihyperglycemic drugs and an increased risk of pancreatitis and certain cancers do not justify making changes in clinical practice, according to a consensus statement on diabetes and cancer released by the ... and more »
